Status:

WITHDRAWN

Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Lead Sponsor:

Barbara Ann Karmanos Cancer Institute

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE1

Brief Summary

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors identify biomarkers related to cancer. Riluzole may help slow the growth of tumor cel...

Detailed Description

OBJECTIVES: Primary * To evaluate the effects of glutamate receptor blockade with riluzole on cellular pathways important in the genesis and progression of disease in women with stage I-IIIA breast ...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Diagnosis of adenocarcinoma of the breast
  • Stage I (T1c)-IIIA disease meeting the following criteria:
  • Large enough (\> 1 cm) to undergo additional multiple core needle biopsies preoperatively
  • Surgically resectable for cure or palliation without first requiring neoadjuvant chemotherapy
  • Patients who have previously been treated for breast cancer, but are judged to have developed a new primary cancer, rather than a recurrence, are eligible
  • PATIENT CHARACTERISTICS:
  • ECOG performance status 0-1
  • ANC ≥ 1,000/mm³
  • Platelet count ≥ 50,000/mm³
  • Liver function tests ≤ 3 times upper limit of normal (ULN)
  • Total bilirubin ≤ 2 times ULN
  • Creatinine ≤ 1.5 mg/dL
  • INR ≤ 25% normal limits
  • Not pregnant or nursing
  • No known history of HIV or AIDS
  • No known history of hepatitis B or C
  • No history of vertigo or Ménière's type of disorder
  • No history of allergic reaction to riluzole or similar compounds
  • PRIOR CONCURRENT THERAPY:
  • No prior estrogen blockers, chemotherapy, radiotherapy, biological therapy, or surgery for the treatment of breast cancer

Exclusion

    Key Trial Info

    Start Date :

    May 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2011

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT00903214

    Start Date

    May 1 2009

    End Date

    June 1 2011

    Last Update

    April 29 2013

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.